111 related articles for article (PubMed ID: 33097681)
1. Development of local vancomycin delivery system from fibrin gel to prevent
Doan VN; Truong TT; Tran HLB
J Biosci; 2020; 45():. PubMed ID: 33097681
[TBL] [Abstract][Full Text] [Related]
2. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
3. In vitro testing of a first-in-class tri-alkylnorspermidine-biaryl antibiotic in an anti-biofilm silicone coating.
Ashton NN; Allyn G; Porter ST; Haussener TJ; Sebahar PR; Looper RE; Williams DL
Acta Biomater; 2019 Jul; 93():25-35. PubMed ID: 30769135
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.
Frapwell CJ; Skipp PJ; Howlin RP; Angus EM; Hu Y; Coates ARM; Allan RN; Webb JS
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122902
[No Abstract] [Full Text] [Related]
5. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms.
Jones SM; Morgan M; Humphrey TJ; Lappin-Scott H
Lancet; 2001 Jan; 357(9249):40-1. PubMed ID: 11197363
[TBL] [Abstract][Full Text] [Related]
6. How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?
Boudjemaa R; Briandet R; Fontaine-Aupart MP; Steenkeste K
Photochem Photobiol Sci; 2017 Sep; 16(9):1391-1399. PubMed ID: 28664201
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections.
Vermote A; Brackman G; Risseeuw MDP; Coenye T; Van Calenbergh S
Bioorg Med Chem; 2016 Oct; 24(19):4563-4575. PubMed ID: 27507109
[TBL] [Abstract][Full Text] [Related]
8. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Chhibber T; Gondil VS; Sinha VR
AAPS PharmSciTech; 2020 Jan; 21(2):43. PubMed ID: 31897806
[TBL] [Abstract][Full Text] [Related]
9. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
10. Bacterial colonization of bone allografts: establishment and effects of antibiotics.
Ketonis C; Barr S; Adams CS; Hickok NJ; Parvizi J
Clin Orthop Relat Res; 2010 Aug; 468(8):2113-21. PubMed ID: 20361282
[TBL] [Abstract][Full Text] [Related]
11. 4-Ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin.
Campbell M; Cho CY; Ho A; Huang JY; Martin B; Gilbert ES
Int J Antimicrob Agents; 2020 Sep; 56(3):106086. PubMed ID: 32663508
[TBL] [Abstract][Full Text] [Related]
12. Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
Shiels SM; Tennent DJ; Akers KS; Wenke JC
Injury; 2017 Oct; 48(10):2095-2100. PubMed ID: 28842287
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
[TBL] [Abstract][Full Text] [Related]
14. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
Chen X; Thomsen TR; Winkler H; Xu Y
BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
[TBL] [Abstract][Full Text] [Related]
15. New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
Revest M; Jacqueline C; Boudjemaa R; Caillon J; Le Mabecque V; Breteche A; Steenkeste K; Tattevin P; Potel G; Michelet C; Fontaine-Aupart MP; Boutoille D
J Antimicrob Chemother; 2016 May; 71(5):1291-9. PubMed ID: 26851611
[TBL] [Abstract][Full Text] [Related]
16.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic functionalised polymers reduce bacterial biofilm and bioburden in a simulated infection of the cornea.
Doroshenko N; Rimmer S; Hoskins R; Garg P; Swift T; Spencer HLM; Lord RM; Katsikogianni M; Pownall D; MacNeil S; Douglas CWI; Shepherd J
Biomater Sci; 2018 Jul; 6(8):2101-2109. PubMed ID: 29881840
[TBL] [Abstract][Full Text] [Related]
18. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
19. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
[TBL] [Abstract][Full Text] [Related]
20. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
